Related Experiment Video
Updated: Jun 24, 2026
08:55
The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
Published on: November 30, 2016
Recent insights on chronic heart failure, cachexia and nutrition
1Service of Internal Medicine-Clinical Nutrition, Burgos Healthcare Complex, Burgos, Spain. mijan@hgy.es
Current Opinion in Clinical Nutrition and Metabolic Care
|April 14, 2009
Summary
Chronic heart failure (CHF) is linked to malnutrition and cachexia, impacting cardiac energetics and inflammation. New nutritional and biological therapies show promise, but more research is needed.
Area of Science:
- Cardiology
- Nutrition Science
- Metabolic Research
Background:
- Chronic heart failure (CHF) is associated with complex nutritional challenges, including cachexia and malnutrition.
- Cardiac muscle energetics and inflammatory pathways are increasingly recognized as key players in heart failure pathogenesis.
- Emerging research highlights the role of microRNAs and altered intestinal function in CHF.
Purpose of the Study:
- To review recent findings on the relationship between chronic heart failure, cachexia, and human nutrition.
- To update epidemiological data concerning heart failure.
- To explore novel therapeutic strategies for cachexia in CHF.
Main Methods:
- Literature review of recent observations and epidemiological data.
- Synthesis of evidence on the pathogenesis of heart failure and cachexia.
- Analysis of emerging nutritional, biological, and hormonal interventions.
Main Results:
- Impaired cardiac energetics and persistent inflammatory catabolic states contribute to heart failure.
- New definitions for cachexia and stratification are established.
- Novel nutrients, substrates, ghrelin, and growth factors show potential in managing malnutrition and cachexia in CHF.
- Altered intestinal function is increasingly implicated in CHF.
Conclusions:
- Effective treatment of cachexia in CHF likely requires a multimodal approach, integrating metabolic, nutritional, immunological, and hormonal strategies.
- Advanced diagnostic and stratification techniques for malnutrition and cardiac cachexia are necessary.
- Well-designed randomized controlled trials are essential to validate emerging therapeutic hypotheses and generate clinical evidence.
Related Concept Videos
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:30Heart Failure VII: Nursing Interventions
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
01:29Cardiomyopathy VI: Nursing Management
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:26Heart Failure III: Clinical Manifestations
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...